.
BioEnterprise

Cleveland, The Medical Capital

700+Biotech, HIT, and Medical Device Businesses

Cleveland’s biomedical industry has grown from 300 companies in 2002 to more than 700 companies today. Imaging, orthopedics, neurostimulation, cardiovascular, biomaterials, health IT, biosensors, and regenerative medicine have attracted the attention of investors and key opinion leaders.

230,000Healthcare and Bioscience Workers

Northeast Ohio is home to 25 universities that offer graduate and undergraduate programs, as well as certificates and diplomas, serving the region’s healthcare, health IT and bioscience industry. Since 2006, these institutions have graduated more than 18,000 bioscience workers.

$2 billionInvested in 390 Bioscience and Health IT Start-Ups

In the past four years, early-stage bioscience and health IT companies have raised over $2 billion, and the innovation and economy continues to grow.

59%Bioscience Industry Grew 59%

Cleveland’s biomedical industry, a $5.6 billion sector, grew 59% from 2000-2014.

32Area Bioscience Investors

Akron ARCHAngel Network
Akron BioInvestments Funds
Arsenal Venture Partners
Blue Point Capital
Bridge Investment Fund
Cascade Partners
Case Technology Ventures
Cleveland Clinic Innovations
Downing Partners
Draper Triangle Ventures
Early Stage Partners
Edison Partners
Edgewater Capital
Everett Partners
Glengary Ventures
GLIDE Fund
Hopen Life Science Ventures
JumpStart Funds
Morgenthaler
Mutual Capital Partners
NDI Healthcare Fund
North Coast Angel Fund
Primus Capital
RIK Enterprises
RMS Investment Corporation
Riverside Company
RiverVest Ventures
Roulston Ventures
Second Generation
Zapis Capital Group

88International and National Investors in Cleveland Biomedical Companies

ABS Capital Partners
Accipiter Capital Management
Aisling Capital
Allos Ventures
Ampersand Capital Partners
Amphion Innovations
Arix Bioscience of London
Aspire Capital
Austin Ventures
Bain Capital Ventures
Baird Capital Partners
Beecken Petty O’Keefe & Company
Behrman Capital
Blue Chip Venture Company
Boston Scientific
Capital Resource Partners
Charter Life Sciences
Chrysalis Ventures
CID Capital
Clayton
Dubilier & Rice
The Compass Group
CompuGroup Medical
CortecGroup
Cowen Group
Cressey & Company
Drive Capital
DSM Venturing
DW Healthcare Partners
Easton Capital Investment Group
EDG Partners
Excel Venture Management
ExOxEmis
Fidelity Biosciences
First Analysis
Fletcher Spaght Ventures
Foundation Medical Partners
Francisco Partners
Goldman Sachs
Great Point Partners
Greatbatch
HealthCare Ventures
Heritage Group
Investor Growth Capital
Kentucky Seed Capital Fund
Kearny Venture Partners
Life Sciences Capital
Maverick Capital
Mayport Venture Partners
MB Venture Partners
Medtronic
MPM Capital
MSD Capital
Norwich Ventures
Oak Investment Partners
Ohio TechAngels
OrbiMed Advisors
Palo Alto Investors
Pappas Ventures
Polaris Partners
Psilos Group
RA Capital
Radius Ventures
River Associates Investments
River Cities Capital Funds
Santė Ventures
Siemens Venture Capital
Summit Partners

56Exits

Cleveland witnessed a record number of bioscience aquisitions in 2015, totaling over $4 billion. Notable exits include CardioInsight to Medtronic, Explorys to IBM, and EnvisionRX to Rite Aid.

Since 2002, the region has seen 56 medical device, biotech, and health IT & services exits.

The Medical Capital

Cleveland, The Medical Capital, is home to internationally renowned clinical, educational, and research institutions, supportive philanthropies, government and economic development engines, funding, talent, strong biomedical innovation and an abundant workforce. Learn more at TheMedicalCapital.com.